Simplex Trading
ALGS icon

Simplex Trading’s Aligos Therapeutics ALGS Stock Holding History

Simplex Trading’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8
Closed – – 8372
2024
Q2 		$0 Sell
8
-36
-82% -$633 ﹤0.01% 8677
2024
Q1 		$1K Buy
+44
New +$876 ﹤0.01% 8518
2023
Q3 		– Sell
-48
Closed -$1K – 8554
2023
Q2 		$1K Sell
48
-15
-24% -$402 ﹤0.01% 8559
2023
Q1 		$1K Buy
+63
New +$2.41K ﹤0.01% 8625
2022
Q2 		– Sell
-52
Closed -$2K – 9852
2022
Q1 		$2K Buy
+52
New +$4.16K ﹤0.01% 9810

Other funds holding ALGS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Simplex Trading's ALGS Position: Q3 2024 in Review

Simplex Trading sold out of Aligos Therapeutics (ALGS) in Q3 2024, closing a stake of 8 shares.

Simplex Trading first reported a position in ALGS in Q1 2022 and held it in 5 quarters. The position peaked at $2K in Q1 2022. 27 funds tracked by Wall St. Rank hold ALGS as of Q3 2024.

  • Simplex Trading reported no remaining Aligos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 8 Aligos Therapeutics shares in Q3 2024.
  • Simplex Trading first reported a position in Aligos Therapeutics in Q1 2022 and held it in 5 quarters.
  • Simplex Trading's Aligos Therapeutics position peaked at $2K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.